drugset / Trial / NCT01152242
Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate whether the within-subject variation in duration of action and time-action profile of glargine measured by isoglycemic clamp will be below prespecified levels.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin glargine | Protein / enzyme biologic | 0.4 iu/kg | — |